Oncology Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Feb '26 Feb 11, 2026	Mar '13 Mar 31, 2013	Jun '11 Jun 30, 2011	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003	Mar '02 Mar 31, 2002
Last Close Price	0.00	1000000.00	10000000.00	12500000.00	52500000.00	325000000.00
Debt / Equity Ratio	-1.86	-1.86	-1.62	-0.14	-	-
Debt / FCF Ratio	555.27	555.27	-	-	-	-
Net Debt / Equity Ratio	-1.82	-1.82	-1.62	-0.10	-1.54	-1.24
Net Debt / EBITDA Ratio	-46.43	-46.43	-	-0.01	1.21	1.75
Net Debt / FCF Ratio	542.69	542.69	-	-0.01	0.85	1.66
Asset Turnover	-	-	-	1.31	1.22	0.84
Quick Ratio	0.04	0.04	-	0.12	1.73	2.42
Current Ratio	0.88	0.88	0.25	0.22	1.79	2.50
Return on Equity (ROE)	-	-	-	-447.14%	-93.71%	-64.37%
Return on Assets (ROA)	-	-	-	-118.19%	-35.06%	-28.79%
Return on Invested Capital (ROIC)	-6.83%	-6.83%	121.89%	-	-	-
Return on Capital Employed (ROCE)	100.70%	100.70%	-14.70%	989.00%	-172.50%	-85.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.